ClinicalTrials.gov
ClinicalTrials.gov Menu

Meditation-Based Stress Reduction in Rheumatoid Arthritis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00071292
Recruitment Status : Completed
First Posted : October 21, 2003
Last Update Posted : March 7, 2008
Sponsor:
Information provided by:
National Center for Complementary and Integrative Health (NCCIH)

Brief Summary:
The purpose of this study is to determine whether a mindfulness meditation-based stress reduction program is useful in relieving symptoms associated with rheumatoid arthritis (RA).

Condition or disease Intervention/treatment Phase
Rheumatoid Arthritis Behavioral: stress reduction program Behavioral: meditation Phase 2

Study Type : Interventional  (Clinical Trial)
Enrollment : 80 participants
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Official Title: Mindfulness Meditation-Based Stress Reduction in Relieving Symptoms Associated With Rheumatoid Arthritis
Study Start Date : July 2003
Study Completion Date : March 2005

Resource links provided by the National Library of Medicine






Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion criteria:

  • Confirmed diagnosis of RA, with doctor's letter or doctors' bill with ICD code 714;
  • 18 years of age or older;
  • Able to read and write English;
  • Able to attend 15 course sessions and questionnaire sessions at Kernan Hospital in Baltimore;
  • Willing to practice skills for 45 minutes to 1 hour per day, 6 days a week;
  • Stable on rheumatoid medications for at least one month.

Exclusion criteria:

  • Major psychiatric illness (bipolar disorder, multiple personality disorder, etc.);
  • Active alcoholism or drug dependency;
  • Scheduled for major surgery during the study period;
  • Enrolled in randomized clinical trial for rheumatoid arthritis during the study period;
  • Planning to move out of the area in the next 12 months;
  • Unwilling to be enrolled in a control group;
  • Use of assistive device other than a cane;
  • Serious health condition(s) that the investigator determines would make it difficult to complete the 6 month study;
  • Diagnosis of fibromyalgia.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00071292


Locations
United States, Maryland
University of Maryland School of Medicine - Kernan Hospital
Baltimore, Maryland, United States, 21207
Sponsors and Collaborators
National Center for Complementary and Integrative Health (NCCIH)
Investigators
Principal Investigator: Brian Berman, MD Director, Center for Integrative Medicine

Publications:
ClinicalTrials.gov Identifier: NCT00071292     History of Changes
Other Study ID Numbers: P50AT000084 ( U.S. NIH Grant/Contract )
Pradhan, Elizabeth
First Posted: October 21, 2003    Key Record Dates
Last Update Posted: March 7, 2008
Last Verified: March 2008

Keywords provided by National Center for Complementary and Integrative Health (NCCIH):
rheumatoid arthritis
stress reduction
meditation
mindfulness
MBSR
mindfulness-based stress reduction
mind-body skills

Additional relevant MeSH terms:
Arthritis
Arthritis, Rheumatoid
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases
Connective Tissue Diseases
Autoimmune Diseases
Immune System Diseases